BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04868877-completion@plaintrial.com
DTSTAMP:20261027T055308Z
DTSTART;VALUE=DATE:202703
SUMMARY:Phase 1/2 Study Evaluating MCLA-129\, a Human Anti-EGFR\, Anti-c-ME
 T Bispecific Antibody\, in Advanced NSCLC and Other Solid Tumors\, Alone a
 nd in Combination — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04868877
URL:https://plaintrial.com/trial/NCT04868877
END:VEVENT
END:VCALENDAR